Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations

W. Abida; A. H. Bryce; N. J. Vogelzang; R. J. Amato; I. Percent; J. D. Shapiro; R. McDermott; A. Hussain; A. Patnaik; D. Petrylak; C. J. Ryan; T. Stanton; J. Zhang; A. D. Simmons; D. Despain; M. Collins; T. Golsorskhi; H. I. Scher; S. Chowdhury

doi:10.1093/annonc/mdy284.002

Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations

W. Abida, A. H. Bryce, N. J. Vogelzang, R. J. Amato, I. Percent, J. D. Shapiro, R. McDermott, A. Hussain, A. Patnaik, D. Petrylak, C. J. Ryan, T. Stanton, J. Zhang, A. D. Simmons, D. Despain, M. Collins, T. Golsorskhi, H. I. Scher, S. Chowdhury

Hematology/Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	viii272
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy284.002
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy284.002

Cite this

Abida, W., Bryce, A. H., Vogelzang, N. J., Amato, R. J., Percent, I., Shapiro, J. D., McDermott, R., Hussain, A., Patnaik, A., Petrylak, D., Ryan, C. J., Stanton, T., Zhang, J., Simmons, A. D., Despain, D., Collins, M., Golsorskhi, T., Scher, H. I., & Chowdhury, S. (2018). Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii272. https://doi.org/10.1093/annonc/mdy284.002

Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations. / Abida, W.; Bryce, A. H.; Vogelzang, N. J. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii272.

Research output: Contribution to journal › Article › peer-review

Abida, W, Bryce, AH, Vogelzang, NJ, Amato, RJ, Percent, I, Shapiro, JD, McDermott, R, Hussain, A, Patnaik, A, Petrylak, D, Ryan, CJ, Stanton, T, Zhang, J, Simmons, AD, Despain, D, Collins, M, Golsorskhi, T, Scher, HI & Chowdhury, S 2018, 'Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii272. https://doi.org/10.1093/annonc/mdy284.002

Abida W, Bryce AH, Vogelzang NJ, Amato RJ, Percent I, Shapiro JD et al. Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii272. doi: 10.1093/annonc/mdy284.002

Abida, W. ; Bryce, A. H. ; Vogelzang, N. J. et al. / Preliminary results from TRITON2 : A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2018 ; Vol. 29. pp. viii272.

@article{db578d08caa2489f9b5b3bda1ca83e73,

title = "Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations",

author = "W. Abida and Bryce, {A. H.} and Vogelzang, {N. J.} and Amato, {R. J.} and I. Percent and Shapiro, {J. D.} and R. McDermott and A. Hussain and A. Patnaik and D. Petrylak and Ryan, {C. J.} and T. Stanton and J. Zhang and Simmons, {A. D.} and D. Despain and M. Collins and T. Golsorskhi and Scher, {H. I.} and S. Chowdhury",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy284.002",

language = "English (US)",

volume = "29",

pages = "viii272",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Preliminary results from TRITON2

T2 - A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations

AU - Abida, W.

AU - Bryce, A. H.

AU - Vogelzang, N. J.

AU - Amato, R. J.

AU - Percent, I.

AU - Shapiro, J. D.

AU - McDermott, R.

AU - Hussain, A.

AU - Patnaik, A.

AU - Petrylak, D.

AU - Ryan, C. J.

AU - Stanton, T.

AU - Zhang, J.

AU - Simmons, A. D.

AU - Despain, D.

AU - Collins, M.

AU - Golsorskhi, T.

AU - Scher, H. I.

AU - Chowdhury, S.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85080569362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85080569362&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy284.002

DO - 10.1093/annonc/mdy284.002

M3 - Article

C2 - 32136624

SN - 0923-7534

VL - 29

SP - viii272

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this